Tyra Biosciences, Inc. Quarterly Depreciation in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tyra Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q2 2024.
  • Tyra Biosciences, Inc. Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
  • Tyra Biosciences, Inc. Depreciation for the twelve months ending June 30, 2024 was $400K, a 19% increase year-over-year.
  • Tyra Biosciences, Inc. annual Depreciation for 2023 was $400K, a 33.3% increase from 2022.
  • Tyra Biosciences, Inc. annual Depreciation for 2022 was $300K, a 114% increase from 2021.
  • Tyra Biosciences, Inc. annual Depreciation for 2021 was $140K, a 198% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $400K $100K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $400K $100K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $400K $100K +$64K +178% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $336K $100K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $336K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $336K $100K +$36K +56.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $300K $36K +$88.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$88.6M $100K -$40.9M -99.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$47.7M $100K -$25.9M -99.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$21.8M $64K -$21.9M -99.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $140K -$88.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $41M +$25M +156% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $26M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $22M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $16M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.